Objectives

At the conclusion of this activity, learners will be able to:

• Expedite adoption of germline and genomic testing in clinical practice
• Interpret next generation sequencing (NGS) results
• Interpret results of a liquid biopsy (ctDNA)
• Explain the role of multi-omics in precision oncology
• Summarize role of biomarkers in selection of targeted therapies and immunotherapies in different cancer types
• Recognize the emerging role of Artificial Intelligence in precision medicine
• Describe common molecular alterations and the role of molecular diagnostic tests in different cancer types
• Summarize recent and emerging data from key studies in clinical and translational cancer research
• Implement strategies designed to improve the quality of cancer care, address barriers to optimal care and enhance the patient experience
• Identify the role of lifestyle intervention in the precision medicine care model
• Identify the role of scentific advances in the field of cancer biology and tumor pathogenesis
• Develop collaborations that will lead to improved clinical trial portfolio and clinical trial participation
• Interact with patients and patient advocacy groups to promote access to molecularly-driven therapies and available clinical trials
• Facilitate patient-oncology experts' interaction and understanding of survivorship challenges in the era of precision medicine